ADVANCED UROTHELIAL CARCINOMA
Clinical trials for ADVANCED UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for tough bladder cancer cases
Disease control Not yet recruitingThis study tests an experimental drug called zanzalintinib in 44 adults with advanced bladder cancer that has gotten worse after previous treatments. Participants take one pill daily to see if it can shrink tumors or slow the cancer's growth. The goal is to find a new option for …
Matched conditions: ADVANCED UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Guru Sonpavde • Aim: Disease control
Last updated May 17, 2026 02:16 UTC
-
New bladder cancer drug faces off against standard therapy in phase 2 trial
Disease control Not yet recruitingThis study compares a new drug called SYS6002 to the current standard drug PADCEV in people with advanced bladder cancer that has worsened after prior treatments. About 100 adults aged 18-80 will be enrolled to see which drug works better and has fewer side effects. The trial has…
Matched conditions: ADVANCED UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC